Prostate Cancer screening blood test uses a combination PSA and epigenetic markers to improve accuracy and reduce false positive results. Further evaluation in larger population cohorts recommended by study authors.

Medical Mythbusting Commentary for February 14, 2023

New blood test may be 94 per cent effective at spotting signs of prostate cancer

Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection